Kinase inhibitors for advanced medullary thyroid carcinoma

Por Schlumberger, Martin, Massicotte, Marie-Hélène, Nascimento, Camila L., Chougnet, Cécile, Baudin, Eric, Leboulleux, Sophie
Publicado em 2012

The Lack of Antitumor Effects of o,p′DDA Excludes Its Role as an Active Metabolite of Mitotane for Adrenocortical Carcinoma Treatment

Por Hescot, Ségolène, Paci, Angelo, Seck, Atmane, Slama, Abdelhamid, Viengchareun, Say, Trabado, Séverine, Brailly-Tabard, Sylvie, Al Ghuzlan, Abir, Young, Jacques, Baudin, Eric, Lombès, Marc
Publicado no Horm Cancer (2014)

Dyslipidemia causes overestimation of plasma mitotane measurements

Por Paci, Angelo, Hescot, Ségolène, Seck, Atmane, Jublanc, Christel, Mercier, Lionel, Vezzosi, Delphine, Drui, Delphine, Quinkler, Marcus, Fassnacht, Martin, Bruckert, Eric, Lombès, Marc, Leboulleux, Sophie, Broutin, Sophie, Baudin, Eric
Publicado no Endocrinol Diabetes Metab Case Rep (2016)

Treatment with Sunitinib for Patients with Progressive Metastatic Pheochromocytomas and Sympathetic Paragangliomas

Por Ayala-Ramirez, Montserrat, Chougnet, Cecile N., Habra, Mouhammed Amir, Palmer, J. Lynn, Leboulleux, Sophie, Cabanillas, Maria E., Caramella, Caroline, Anderson, Pete, Al Ghuzlan, Abir, Waguespack, Steven G., Deandreis, Desirée, Baudin, Eric, Jimenez, Camilo
Publicado em 2012

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

Por Wells, Samuel A., Robinson, Bruce G., Gagel, Robert F., Dralle, Henning, Fagin, James A., Santoro, Massimo, Baudin, Eric, Elisei, Rossella, Jarzab, Barbara, Vasselli, James R., Read, Jessica, Langmuir, Peter, Ryan, Anderson J., Schlumberger, Martin J.
Publicado em 2012

A Phase II Study of BEZ235 in Patients with Everolimus-resistant, Advanced Pancreatic Neuroendocrine Tumours

Por FAZIO, NICOLA, BUZZONI, ROBERTO, BAUDIN, ERIC, ANTONUZZO, LORENZO, HUBNER, RICHARD A., LAHNER, HARALD, DE HERDER, WOUTER W., RADERER, MARKUS, TEULÉ, ALEXANDRE, CAPDEVILA, JAUME, LIBUTTI, STEVEN K., KULKE, MATTHEW H., SHAH, MANISHA, DEY, DEBARSHI, TURRI, SABINE, AIMONE, PAOLA, MASSACESI, CRISTIAN, VERSLYPE, CHRIS
Publicado no Anticancer Res (2016)

IGF2 Promotes Growth of Adrenocortical Carcinoma Cells, but Its Overexpression Does Not Modify Phenotypic and Molecular Features of Adrenocortical Carcinoma

Por Guillaud-Bataille, Marine, Ragazzon, Bruno, de Reyniès, Aurélien, Chevalier, Claire, Francillard, Isabelle, Barreau, Olivia, Steunou, Virginie, Guillemot, Johann, Tissier, Frédérique, Rizk-Rabin, Marthe, René-Corail, Fernande, Ghuzlan, Abir Al, Assié, Guillaume, Bertagna, Xavier, Baudin, Eric, Le Bouc, Yves, Bertherat, Jérôme, Clauser, Eric
Publicado em 2014

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

Por Yao, James C., Lombard-Bohas, Catherine, Baudin, Eric, Kvols, Larry K., Rougier, Philippe, Ruszniewski, Philippe, Hoosen, Sakina, St. Peter, Jessica, Haas, Tomas, Lebwohl, David, Van Cutsem, Eric, Kulke, Matthew H., Hobday, Timothy J., O'Dorisio, Thomas M., Shah, Manisha H., Cadiot, Guillaume, Luppi, Gabriele, Posey, James A., Wiedenmann, Bertram
Publicado no J Clin Oncol (2010)